David Kugler is Vice President of Research & Development at Cartography and is the Global Asset Lead for Cartography’s lead program CBI-1214. He has 20+ years of experience with prior roles at Amgen, Juno Therapeutics, Celgene and Bristol Myers Squibb and has worked across autoimmunity & inflammation, oncology as well as infectious disease therapeutic areas. David is a cellular immunologist and T cell biologist, and completed his PhD studying immune regulation at Johns Hopkins University in partnership with the National Institute of Allergy and Infectious Diseases (NIAID). Outside of work, David spends time traveling with his family and exploring the outdoors.